Power in the pivotal study (EU) [Power / Sample Size]

posted by valivetiananth – India, 2018-05-31 15:49 (2154 d 11:10 ago) – Posting: # 18832
Views: 8,311

Dear All,

Greetings!!!

We have conducted a pivotal study for Europe with 48 subjects considering ~80% power, ISCV: 23%. The study was bioequivalent and 90% CI is within 80-125 for both Cmax & AUCt.

Power of Cmax and AUCt are 92% & 66% respectively. Kindly guide us how to justify the power less than 80% to HA.


Thanks
Valiveti

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,655 registered users;
55 visitors (0 registered, 55 guests [including 5 identified bots]).
Forum time: 02:59 CEST (Europe/Vienna)

So far as I can remember,
there is not one word in the Gospels
in praise of intelligence.    Bertrand Russell

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5